Ken Fisher’s Argos Therapeutics, Inc. ARGS Stock Holding History

Ken Fisher’s Portfolio ARGS Stock Details ARGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-12,555	Closed	–	–	1078
2022 Q3	$0	Hold	12,555	–	–	﹤0.01%	1006
2022 Q2	$0	Hold	12,555	–	–	﹤0.01%	1015
2022 Q1	$0	Hold	12,555	–	–	﹤0.01%	1037
2021 Q4	$0	Hold	12,555	–	–	﹤0.01%	1022
2021 Q3	$0	Hold	12,555	–	–	﹤0.01%	984
2021 Q2	$0	Buy	12,555 +15	+0.1%	–	﹤0.01%	988
2021 Q1	$0	Buy	+12,540	New	–	﹤0.01%	993

Ken Fisher's ARGS Position: Q4 2022 in Review

Ken Fisher sold out of Argos Therapeutics, Inc. (ARGS) in Q4 2022, closing a stake of 12,555 shares.

Ken Fisher first reported a position in ARGS in Q1 2021 and held it in 7 quarters. The position peaked at $0 in Q3 2022. 0 funds tracked by Wall St. Rank hold ARGS as of Q4 2022.

Ken Fisher reported no remaining Argos Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Ken Fisher sold 12,555 Argos Therapeutics, Inc. shares in Q4 2022.
Ken Fisher first reported a position in Argos Therapeutics, Inc. in Q1 2021 and held it in 7 quarters.
Ken Fisher's Argos Therapeutics, Inc. position peaked at $0 in Q3 2022.
0 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q4 2022.

Based on Fisher Asset Management's 13F filing for Q4 2022, filed 3 Feb 2023.